Seeing Is Believing
Currently out of the existing stock ratings of Paul Knight, 124 are a BUY (91.18%), 12 are a HOLD (8.82%).
Analyst Paul Knight, currently employed at KEYBANK, carries an average stock price target met ratio of 51.12% that have a potential upside of 35.91% achieved within 150 days.
Paul Knight’s has documented 252 price targets and ratings displayed on 22 stocks. The coverage is on Healthcare, Basic Materials, Technology, Industrials sectors.
Most recent stock forecast was given on TECH, Bio-Techne Corp at 09-Apr-2025.
Analyst best performing recommendations are on CYRX (CRYOPORT).
The best stock recommendation documented was for CYRX (CRYOPORT) at 1/19/2021. The price target of $75 was fulfilled within 3 days with a profit of $10.82 (16.86%) receiving and performance score of 56.2.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Buy
$155
$43.08 (38.49%)
$165
8 days ago
(29-May-2025)
7/10 (70%)
$41.72 (36.83%)
276
Buy
$140
$28.08 (25.09%)
$159
15 days ago
(22-May-2025)
9/16 (56.25%)
$30.32 (27.64%)
112
Hold
$116
$4.08 (3.65%)
$155
1 months 16 days ago
(21-Apr-2025)
14/20 (70%)
$15.74 (15.70%)
386
Hold
$115
$3.08 (2.75%)
$145
1 months 27 days ago
(10-Apr-2025)
12/13 (92.31%)
$15.05 (15.06%)
134
Hold
$150
$38.08 (34.02%)
$147
5 months 24 days ago
(13-Dec-2024)
8/8 (100%)
$11.26 (8.12%)
89
Which stock is Paul Knight is most bullish on?
Which stock is Paul Knight is most reserved on?
What Year was the first public recommendation made by Paul Knight?